ArticleCell reports. Medicine2025

Drug screening in 3D microtumors reveals DDR1/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblasts.

Nao Nishida-Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.